Small anticancer drug release by light
Aiming to engineer simple, neutral, strongly amphiphilic photoactive nanoparticles (NPs) to specifically target cancer cell lysosomes for drug transport and
A forum for researchers, students and applicants in the field of cyclodextrin technology
Aiming to engineer simple, neutral, strongly amphiphilic photoactive nanoparticles (NPs) to specifically target cancer cell lysosomes for drug transport and
US patent application US2022409653 entitled “METHOD FOR PREVENTING ENTRY AND REPLICATION OF ENVELOPED VIRUSES” descibes a method for the reduction
The important role of gasotransmitters in physiology and pathophysiology suggest employing gasotransmitters for biomedical treatment. Unfortunately, the difficulty in storage
A group of researchers at CycloLab continuously follow the new drug composition approvals especially those benefiting the use of cyclodextrins.
The status of US patent application 17/344,217 (“Purification of sulfobutylated cyclodextrins with specific ion exchange resins” by CycloLab, Hungary) was
Two chapters of a book under preparation were found on the internet (IntechOpen): Ludmila Aricov, Anca Ruxandra Leontieș, Iulia Matei
The 10th Annual International Symposium of Drug Delivery Systems (SDDS-2023) postponed from the last year is going to be held
Cyclodextrin metal-organic frameworks (CD-MOF) are a class of biocompatible MOFs with a great potential in drug delivery applications. Original CD-MOF
Tattoos are already used in the clinic to mark where doctors will apply radiation treatments, to correct skin discoloration, to mark
The incorporation of CDs in dermopharmaceutical and cosmetics formulations has received much attention since the late 1970 s by enhancing